
[Federal Register Volume 80, Number 107 (Thursday, June 4, 2015)]
[Notices]
[Page 31909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13633]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0002]


Withdrawal of Approval of New Animal Drug Application; 
Chlortetracycline

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of withdrawal of approval.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval 
of a new animal drug application (NADA). This action is being taken at 
the sponsors' request because this product is no longer manufactured or 
marketed.

DATES: Withdrawal of approval is effective June 15, 2015.

FOR FURTHER INFORMATION CONTACT: Sujaya Dessai, Center for Veterinary 
Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., 
Rockville, MD 20855, 240-276-9075, sujaya.dessai@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: The Hartz Mountain Corp., 400 Plaza Dr., 
Secaucus, NJ 07094 has requested that FDA withdraw approval of NADA 
065-222 for KEET LIFE (chlortetracycline) Bird Seed because this 
product is no longer manufactured or marketed.
    Therefore, under authority delegated to the Commissioner of Food 
and Drugs and redelegated to the Center for Veterinary Medicine, and in 
accordance with 21 CFR 514.116 Notice of withdrawal of approval of 
application, notice is given that approval of NADA 065-222, and all 
supplements and amendments thereto, is hereby withdrawn, effective June 
15, 2015.
    The animal drug regulations are not being amended to reflect the 
voluntary withdrawal of approval of this application because it is not 
codified.

    Dated: June 1, 2015.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2015-13633 Filed 6-3-15; 8:45 am]
 BILLING CODE 4164-01-P


